2017 annual financial data

Vistagen Therapeutics 2017 Net margin

Vistagen Therapeutics 2017 net margin with verified reported values.

Direct answer

Net margin was -820.44%.

Operating income was -10,248,500 USD and net income was -10,255,500 USD.
Operating cash flow was -7,262,100 USD.

Get free Vistagen Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
1,250,000 USD
Operating income
-10,248,500 USD
Net income
-10,255,500 USD
Operating cash flow
-7,262,100 USD